FFA
NMRA icon

Farther Finance Advisors’s Neumora Therapeutics NMRA Stock Holding History

Farther Finance Advisors’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$472 Buy
+792
New +$1.1K ﹤0.01% 5756

Other funds holding NMRA

LPT
Legacy Private Trust Neenah, Wisconsin $1.83B AUM 13% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's NMRA Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Neumora Therapeutics (NMRA) in Q3 2026: 792 shares worth $472. The stake represents ﹤0.01% of the portfolio and ranks #5756 among its holdings.

6 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.

  • Farther Finance Advisors held 792 shares of Neumora Therapeutics worth $472 as of Q3 2026.
  • Neumora Therapeutics was a new Farther Finance Advisors position in Q3 2026.
  • Neumora Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5756 holding.
  • 6 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.